Atlas Venture Fund X, L.P. - Dec 14, 2022 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
10%+ Owner
Signature
Atlas Venture Fund X, L.P., By: Atlas Venture Associates X, L.P., its general partner, by Atlas Associates X, LLC, its general partner, By: /s/ Ommer Chohan, Ommer Chohan, Chief Financial Officer
Stock symbol
KYMR
Transactions as of
Dec 14, 2022
Transactions value $
-$11,985,954
Form type
4
Date filed
12/16/2022, 04:03 PM
Previous filing
Nov 4, 2022
Next filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KYMR Common Stock Sale -$3.42M -113K -2.1% $30.28 5.25M Dec 14, 2022 Direct F1, F2, F3
transaction KYMR Common Stock Sale -$3.18M -101K -1.93% $31.44 5.15M Dec 14, 2022 Direct F1, F3, F4
transaction KYMR Common Stock Sale -$1.77M -54.7K -1.06% $32.33 5.1M Dec 14, 2022 Direct F1, F3, F5
transaction KYMR Common Stock Sale -$467K -14K -0.27% $33.34 5.08M Dec 14, 2022 Direct F1, F3, F6
transaction KYMR Common Stock Sale -$454K -13.3K -0.26% $34.02 5.07M Dec 14, 2022 Direct F1, F3, F7
transaction KYMR Common Stock Sale -$956K -31.6K -3.15% $30.28 970K Dec 14, 2022 See footnote F1, F2, F8
transaction KYMR Common Stock Sale -$891K -28.3K -2.92% $31.44 942K Dec 14, 2022 See footnote F1, F4, F8
transaction KYMR Common Stock Sale -$495K -15.3K -1.63% $32.33 926K Dec 14, 2022 See footnote F1, F5, F8
transaction KYMR Common Stock Sale -$131K -3.92K -0.42% $33.34 922K Dec 14, 2022 See footnote F1, F6, F8
transaction KYMR Common Stock Sale -$127K -3.73K -0.4% $34.02 919K Dec 14, 2022 See footnote F1, F7, F8
transaction KYMR Common Stock Sale -$76.8K -2.56K -0.05% $30.00 5.07M Dec 15, 2022 Direct F1, F3, F9
transaction KYMR Common Stock Sale -$21.5K -717 -0.08% $30.00 918K Dec 15, 2022 See footnote F1, F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.95 to $30.94 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (9).
F3 These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. ("AVA X LP"). Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. Each of AVA X LP and AVA X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of its pecuniary interest therein, if any.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.95 to $31.945 inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.95 to $32.94 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.95 to $33.89 inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.95 to $34.20 inclusive.
F8 The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. ("AVOF I"). Atlas Venture Associates Opportunity I, L.P. ("AVAO LP") is the general partner of AVOF I. Atlas Venture Associates Opportunity I, LLC ("AVAO LLC") is the general partner of AVAO LP. Each of AVAO LP and AVAO LLC disclaims Section 16 beneficial ownership of the securities held by AVOF I, except to the extent of its pecuniary interest therein, if any.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.95 to $30.20 inclusive.